Integrating Kaplan–Meier and LASSO Cox regression analyses, we defined a four-gene signature—UCK2, FABP5, CA9, and CYP2C9—that stratifies HCC patients into high- and low-risk groups with significant survival differences. The gene discussed is CYP2C9; the disease is hepatocellular carcinoma.